7 Stocks Rising in Premarket Trading Friday

The rising stocks during premarket trading in the stock market on Friday include Moderna, Ross Stores, BioNTech, Pfizer and Microsoft.
Author:
Updated:
Original:

Dow futures edged lower Friday as markets reacted to Treasury Steve Mnuchin recalling nearly half a billion dollars in coronavirus aid from the Federal Reserve.

The earnings reports that are expected Friday are Foot Locker  (FL) - Get Report and Hibbett Sports  (HIBB) - Get Report to end a busy week of earnings.

Here are the best stocks in the premarket trading by their performance in percentage change. The stocks selected must be a greater than $20 share price.

BioNTech BNTX | Increased +5.13%

BioNTech  (BNTX) - Get Report is the selected partner for the Moderna and Pfizer vaccine. Eli Lilly  (LLY) - Get Report also received FDA approval on Friday for its vaccine despite the WHO administration casting doubt about Gilead's  (GILD) - Get Report remdesivir, which is a key component of the drug. 

Ross Stores ROST | Increased +3.54%

Ross Stores  (ROST) - Get Report shares are rising after reporting stronger than expected revenue during its third-quarter report. Three analysts have upgraded the stock and raised their price target after the news.

Moderna MRNA | Increased +2.85%

Moderna  (MRNA) - Get Report and BioNTech are expected to receive conditional EU approval to distribute their Covid-19 vaccines starting next month in a synchronized effort with the U.S.

Pinduoduo | Increased +2.70%

Chinese e-commerce Pinduoduo  (PDD) - Get Report jumped after reporting earnings earlier in Nov. and reported its first-ever profit.

Microsoft | Increased +0.13%

Microsoft  (MSFT) - Get Report received an upgrade by Oppenheimer in early Nov. on cloud strength with a new price target of $260. The stock closed trading on Thursday at $212.42.

Pfizer PFE | Increased +1.55%

Pfizer  (PFE) - Get Report filed for emergency FDA approval for its Covid-19 vaccine so it can start distributed the vaccine starting in Dec. with its partner BioNTech. 

JD.com JD | Increased +0.76%

JD.com  (JD) - Get Report reported earnings earlier this week and beat earnings forecasts but fell short on revenue.